Different characteristics of peripartum cardiomyopathy between patients complicated with and without hypertensive disorders: Results from the Japanese nationwide survey of peripartum cardiomyopathy

Circulation Journal

Volumn 75, Issue 8, 2011, Pages 1975-1981

  Kamiya, Chizuko A ^a   Kitakaze, Masafumi ^a   Ishibashi Ueda, Hatsue ^a   Nakatani, Satoshi ^b   Murohara, Toyoaki ^c   Tomoike, Hitonobu ^d   Ikeda, Tomoaki ^a  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d SAKAKIBARA HEART INSTITUTE   (Japan)

Author keywords

Cardiomyopathy; Heart failure; Hypertension; Pregnancy; Prognosis

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; UTERUS SPASMOLYTIC AGENT;

ADULT; AGE; ARTICLE; CARDIOVASCULAR PARAMETERS; CESAREAN SECTION; CLINICAL FEATURE; CONTROLLED STUDY; CONVALESCENCE; DELIVERY; DISEASE ASSOCIATION; ECLAMPSIA; FEMALE; FOLLOW UP; HEALTH SURVEY; HEART FAILURE; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HOSPITALIZATION; HUMAN; JAPAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; MATERNAL MORTALITY; PARITY; PERIPARTUM CARDIOMYOPATHY; PREECLAMPSIA; PREGNANCY; QUESTIONNAIRE; RETROSPECTIVE STUDY; TWIN PREGNANCY; VAGINAL DELIVERY;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; CARDIOMYOPATHIES; CESAREAN SECTION; DATA COLLECTION; FEMALE; HEART FUNCTION TESTS; HUMANS; JAPAN; LENGTH OF STAY; PERIPARTUM PERIOD; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 79960786700     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-10-1214     Document Type: Article

References (29)

1. Demakis JG, Rahimtoola SH. Peripartum cardiomyopathy. Circulation 1971; 44: 964-968.
2. Sliwa K, Fett J, Elkayam U. Peripartum cardiomyopathy. Lancet 2006; 368: 687-693.
3. Selle T, Renger I, Labidi S, Bultmann I, Hilfiker-Kleiner D. Reviewing peripartum cardiomyopathy: Current state of knowledge. Future Cardiol 2009; 5: 175-189.
4. Brar SS, Khan SS, Sandhu GK, Jorgensen MB, Parikh N, Hsu JW, et al. Incidence, mortality, and racial differences in peripartum cardiomyopathy. Am J Cardiol 2007; 100: 302-304.
5. Witlin AG, Mabie WC, Sibai BM. Peripartum cardiomyopathy: Anonymous diagnosis. Am J Obstet Gynecol 1997; 176: 182-188.
6. Pearson GD, Veille JC, Rahimtoola S, Hsia J, Oakley CM, Hosenpud JD, et al. Peripartum cardiomyopathy: National Heart, Lung, and Blood Institute and Office of Rare Diseases (National Institutes of Health) workshop recommendations and review. JAMA 2000; 283: 1183-1188.
7. Elkayam U, Akhter MW, Singh H, Khan S, Bitar F, Hameed A, et al. Pregnancy-associated cardiomyopathy: Clinical characteristics and a comparison between early and late presentation. Circulation 2005; 111: 2050-2055.
8. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 2000; 183: S1-S22.
9. Sliwa K, Skudicky D, Bergemann A, Candy G, Puren A, Sareli P. Peripartum cardiomyopathy: Analysis of clinical outcome, left ventricular function, plasma levels of cytokines and Fas/APO-1. J Am Coll Cardiol 2000; 35: 701-705.
10. Sliwa K, Forster O, Libhaber E, Fett JD, Sundstrom JB, Hilfiker-Kleiner D, et al. Peripartum cardiomyopathy: Inflammatory markers as predictors of outcome in 100 prospectively studied patients. Eur Heart J 2006; 27: 441-446.
11. Modi KA, Illum S, Jariatul K, Caldito G, Reddy PC. Poor outcome of indigent patients with peripartum cardiomyopathy in the United States. Am J Obstet Gynecol 2009; 201: 171e1-e5.
12. Demakis JG, Rahimtoola SH, Sutton GC, Meadows WR, Szanto PB, Tobin JR, et al. Natural course of peripartum cardiomyopathy. Circulation 1971; 44: 1053-1061.
13. Fett JD, Christie LG, Carraway RD, Murphy JG. Five-year prospective study of the incidence and prognosis of peripartum cardiomyopathy at a single institution. Mayo Clin Proc 2005; 80: 1602-1606.
14. Lang RM, Pridjian G, Feldman T, Neumann A, Lindheimer M, Borow KM. Left ventricular mechanics in preeclampsia. Am Heart J 1991; 121: 1768-1775.
15. Simmons LA, Gillin AG, Jeremy RW. Structural and functional changes in left ventricle during normotensive and preeclamptic pregnancy. Am J Physiol Heart Circ Physiol 2002; 283: H1627-H1633.
16. Bamfo JE, Kametas NA, Chambers JB, Nicolaides KH. Maternal cardiac function in normotensive and pre-eclamptic intrauterine growth restriction. Ultrasound Obstet Gynecol 2008; 32: 682-686.
17. Rafik Hamad R, Larsson A, Pernow J, Bremme K, Eriksson MJ. Assessment of left ventricular structure and function in preeclampsia by echocardiography and cardiovascular biomarkers. J Hypertens 2009; 27: 2257-2264.
18. Kai H, Kudo H, Takayama N, Yasuoka S, Kajimoto H, Imaizumi T. Large blood pressure variability and hypertensive cardiac remodeling: Role of cardiac inflammation. Circ J 2009; 73: 2198-2203.
19. Gleicher N, Elkayam U. Peripartum cardiomyopathy, an autoimmune manifestation of allograft rejection? Autoimmun Rev 2009; 8: 384-387.
20. Yoshikawa T, Baba A, Nagatomo Y. Autoimmune mechanisms underlying dilated cardiomyopathy. Circ J 2009; 73: 602-607.
21. Bultmann BD, Klingel K, Nabauer M, Wallwiener D, Kandolf R. High prevalence of viral genomes and inflammation in peripartum cardiomyopathy. Am J Obstet Gynecol 2005; 193: 363-365.
22. Nishi I, Ishimitsu T, Ishizu T, Ueno Y, Suzuki A, Seo Y, et al. Peripartum cardiomyopathy and biventricular thrombi. Circ J 2002; 66: 863-865.
23. van Spaendonck-Zwarts KY, van Tintelen JP, van Veldhuisen DJ, van der Werf R, Jongbloed JD, Paulus WJ, et al. Peripartum cardiomyopathy as a part of familial dilated cardiomyopathy. Circulation 2010; 121: 2169-2175.
24. Morales A, Painter T, Li R, Siegfried JD, Li D, Norton N, et al. Rare variant mutations in pregnancy-associated or peripartum cardiomyopathy. Circulation 2010; 121: 2176-2182.
25. Ntusi NB, Mayosi BM. Aetiology and risk factors of peripartum cardiomyopathy: A systematic review. Int J Cardiol 2009; 131: 168-179.
26. Hilfiker-Kleiner D, Kaminski K, Podewski E, Bonda T, Schaefer A, Sliwa K, et al. A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy. Cell 2007; 128: 589-600.
27. Leanos-Miranda A, Marquez-Acosta J, Cardenas-Mondragon GM, Chinolla-Arellano ZL, Rivera-Leanos R, Bermejo-Huerta S, et al. Urinary prolactin as a reliable marker for preeclampsia, its severity, and the occurrence of adverse pregnancy outcomes. J Clin Endocrinol Metab 2008; 93: 2492-2499.
28. Reuwer AQ, Reuwer PJ, van der Post JA, Cramer MJ, Kastelein JJ, Twickler MT. Prolactin fragmentation by trophoblastic matrix metalloproteinases as a possible contributor to peripartum cardiomyopathy and pre-eclampsia. Med Hypotheses 2010; 74: 348-352.
29. Goland S, Modi K, Bitar F, Janmohamed M, Mirocha JM, Czer LSC, et al. Clinical profile and predictors of complications in peripartum cardiomyopathy. J Card Fail 2009; 15: 645-650.